Investments – Page 11

Sanofi’s Strategic Acquisition of Principia Bears Fruit with Rilzabrutinib’s Phase III Success

1 year ago talkbio0Tagged Acquisition (action), Biotechnology, Clinical Trials, Drug Development, Drug Industry, Investments, Phase III, Principia, Rilzabrutinib, sanofi, strategic, Success

Sanofi, Principia, acquisition, Rilzabrutinib, Phase III, clinical trial, success, strategic investment, pharmaceutical industry, biotechnology, drug development.

BMS Expands CAR-T Therapy Capabilities with Strategic $380 Million Investment in Cellares

1 year ago talkbio0Tagged Automation, Biotechnology, Burning Mouth Syndrome, Cancer Therapeutic Procedure, Capacity, CAR-T, Cell Therapy, Cellares, expansion, Investments, Manufacture, squibb

BMS, Bristol Myers Squibb, Cellares, CAR-T therapy, cell therapy, cancer treatment, biotechnology, investment, capacity expansion, manufacturing, automation.

Pathios Secures $25M in Funding from BMS to Advance GPR65 Checkpoint Inhibitor Development

1 year ago1 year ago talkbio0Tagged Biotechnology, BMS, Bristol Myers Squibb, checkpoint inhibitor, Drug Development, GPR65 gene, Immunotherapy for cancer, Investments, Pathios

Pathios, Bristol-Myers Squibb (BMS), funding, GPR65, checkpoint inhibitor, cancer immunotherapy, drug development, biotechnology, investment.

Canaan Secures Additional $100M for Biopharma Fund and Welcomes Pfizer Veteran to Team

1 year ago talkbio0Tagged Biopharma Fund, Canaan, Investments, Pfizer Veteran

Canaan, Biopharma Fund, $100M Investment, Pfizer Veteran

Fujifilm Diosynth Announces $1.2B Expansion in North Carolina, Aiming to Employ 1,400

1 year ago talkbio0Tagged Biopharmaceutical manufacturing, Biotechnology, CDMO facility, end-to-end cell culture, expansion, Fujifilm, Holly Springs, Investments, Japanese language, North Carolina, Occupations

Fujifilm Diosynth Biotechnologies, $1.2 billion expansion, North Carolina, Holly Springs, 1/400 jobs, Biopharmaceutical manufacturing, End-to-end cell culture CDMO facility, Japanese investment

AstraZeneca Commits £650M Expansion for UK Vaccine Hub and Research Campus

1 year ago talkbio0Tagged AstraZeneca, Cambridge/, Economic Growth, England, Environment, Government support, Investments, Life sciences sector, Occupations, operationally, pandemic preparedness, public health protection, Renewable Energy, research, Research and Development, Speke/ Liverpool, Surgical construction, Taxes, UK vaccine

AstraZeneca, £650 million investment, UK vaccine hub, Speke/ Liverpool, Renewable energy, Operationally net-zero facility, Research and Development (R&D) campus, Cambridge/ England, Job creation, Pandemic preparedness, Public health protection, Economic growth, Government support, Tax environment, Life sciences sector